Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Alcon Finalizes Acquisition of BELKIN Vision
Alcon has finalized its acquisition of BELKIN Vision, marking a significant expansion of its glaucoma treatment offerings. The acquisition, valued at $81M upfront, with potential additional payments up to $385M contingent on sales milestones, includes BELKIN Vision’s innovative Direct Selective…
Top 10 Ophthalmologists Who Changed the Field
Ophthalmology, the branch of medicine that deals with the diagnosis and treatment of eye-related diseases and disorders, has made great strides in the past century. The following ten individuals are among the most influential and accomplished ophthalmologists in history, each…
Thea Pharma’s New Website for Iyuzeh Support
Thea Pharmaceuticals launched a new website aimed at providing comprehensive resources to ophthalmologists for the effective use of latanoprost ophthalmic solution 0.005%, marketed as Iyuzeh, in patient care. This initiative comes in response to feedback from Eye Care Professionals (ECPs)…
VSY Biotechnology: Who Will Shine at the OSA 2024?
VSY Biotechnology GmbH, a leading company with innovative ophthalmic solutions, is now accepting submissions for Ophthalmology Star Awards (OSA) 2024 from eye care professionals worldwide. The awards aim to celebrate and promote novel research and advancements in ophthalmology, with winners…
NVISION Eye Centers Partners with Parkhurst NuVision
NVISION Eye Centers, a prominent provider of eye care services nationwide, announced a strategic collaboration with Parkhurst NuVision of San Antonio, Texas, through its subsidiary NVision Clinical Research, LLC. This partnership aims to advance clinical trials in ophthalmology drug development,…
Notal Vision’s OCT Promises Advances in Wet AMD Management
Notal Vision announced findings from a pioneering clinical trial using home-based optical coherence tomography (OCT) to oversee patients with wet age-related macular degeneration (AMD). Published in Retina, the results highlighted a notable reduction in office visits and treatment frequency, while…
ANI Pharmaceuticals to Acquire Alimera Sciences in $381M Deal
ANI Pharmaceutical has signed a definitive agreement to acquire Alimera at approximately $381 million. The agreement has been approved by both companies’ Boards of Directors and is anticipated to close in the late third quarter of 2024. Alimera Sciences, a…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
Primary Open Angle Glaucoma (POAG)
A subtype of glaucomas known as primary open angle glaucoma (POAG) is characterized by an open, seemingly normal anterior chamber angle and elevated intraocular pressure (IOP), with no additional underlying disease. Secondary glaucoma is a condition where the elevated IOP…
What Is Vision Therapy and Who Needs It
Vision therapy is a specialized form of optometric care that utilizes a series of customized visual exercises and equipment to improve visual skills and processing. Often described as physical therapy for the eyes and brain, vision therapy aims to enhance…